>>> Up
* Birkenstock PT Raised to $70 from $63 at Stifel
* Getinge Raised to Hold at Nordea
* Nemetschek Raised to Buy at Baader Helvea; PT 118 euros
* Nemetschek Raised to Buy at Baader Helvea; PT 118 euros
* Ormat Rated New Neutral at Piper Sandler; PT $78
* Pharming PT Raised to 2.15 euros from 1.60 euros at RBC
* Tapestry Raised to Buy at Jefferies; PT $80
>>> Down
>>> Down
* C3.ai Cut to Underweight at KeyBanc; PT $29
* Kamux Cut to Reduce at Inderes; PT 2.80 euros (+)
* Munich Re Cut to Neutral at UBS (+)
* Netcompany Cut to Hold at Carnegie; PT 350 kroner
* SAP ADRs Downgraded to Hold at CFRA on Valuation Concerns
* Spar Nord Cut to Hold at SEB Equities; PT 210 kroner
* Spar Nord Cut to Hold at SEB Equities; PT 210 kroner
* Galderma cut to Hold from Buy at Vontobel, PT from CHF 90 to CHF96
* Zurich Ins. Cut to Sell at UBS (+)
>>> Initiation
>>> Initiation
* Aurubis Rated New Buy at Kepler Cheuvreux; PT 93.70 euros (+)
* Baker Hughes Rated New Overweight at Piper Sandler; PT $53
* Canal+ Rated New Outperform at Oddo BHF; PT 380 pence
* Canal+ Rated New Buy at CIC; PT 450 pence (+)
* Canal+ Rated New Buy at CIC; PT 450 pence (+)
* Flowtech Fluidpower Rated New Buy at Canaccord; PT 130 pence (+)
* Halliburton Rated New Overweight at Piper Sandler; PT $36
* Havas Rated New Outperform at Oddo BHF; PT 2.30 euros
* Havas NV Rated New Buy at CIC; PT 2.20 euros (+)
* Havas NV Rated New Buy at CIC; PT 2.20 euros (+)
* HUTCHMED China ADRs Rated New Buy at Daiwa; PT $23
* Norion Bank Rated New Hold at Kepler Cheuvreux; PT 42 kronor (+)
* SLB Rated New Neutral at Piper Sandler; PT $47
* TechnipFMC Rated New Overweight at Piper Sandler; PT $39
* Weatherford Reinstated Neutral at Piper Sandler; PT $87
* Weatherford Reinstated Neutral at Piper Sandler; PT $87
>>> Call
* Goldman Sachs Strategists Favor US Defensives for Next Half Year (+)
* Nemetschek on Track for Full-Year Goals, Baader Helvea Upgrades
* Nemetschek on Track for Full-Year Goals, Baader Helvea Upgrades
* SBB Court Case ‘Significantly Derisked’ After Swap, Arctic Says
* UBS Downgrades Zurich and Munich Re in Insurance Outlook Note (+)